|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 78
Zeitschriftenartikel
Kahnert, Kathrin 
ORCID: https://orcid.org/0000-0001-9633-3368; Lempert, Lilli Maria; Behr, Jürgen ORCID: https://orcid.org/0000-0002-9151-4829; Elsner, Laura; Bolt, Toki; Tufman, Amanda und Kauffmann-Guerrero, Diego ORCID: https://orcid.org/0000-0003-1471-3290
(2023):
Hyperinflation and reduced diffusing capacity predict prognosis in SCLC: value of extended pre-therapeutic lung function testing.
In: Therapeutic Advances in Respiratory Disease, Bd. 17
[PDF, 772kB]
ORCID: https://orcid.org/0000-0001-9633-3368; Lempert, Lilli Maria; Behr, Jürgen ORCID: https://orcid.org/0000-0002-9151-4829; Elsner, Laura; Bolt, Toki; Tufman, Amanda und Kauffmann-Guerrero, Diego ORCID: https://orcid.org/0000-0003-1471-3290
(2023):
Hyperinflation and reduced diffusing capacity predict prognosis in SCLC: value of extended pre-therapeutic lung function testing.
In: Therapeutic Advances in Respiratory Disease, Bd. 17
[PDF, 772kB]
Sellmer, Laura; Kovács, Julia; Walter, Julia; Kumbrink, Jörg; Neumann, Jens; Kauffmann-Guerrero, Diego; Kiefl, Rosemarie; Schneider, Christian; Jung, Andreas; Behr, Jürgen und Tufman, Amanda
(27. Juni 2022):
Markers of Immune Cell Exhaustion as Predictor of Survival in Surgically-Treated Early-Stage NSCLC.
In: Frontiers in Immunology, Bd. 13
[PDF, 1MB]
Walter, Julia; Sellmer, Laura; Kahnert, Kathrin; Kiefl, Rosemarie; Syunyaeva, Zulfiya; Kauffmann-Guerrero, Diego; Manapov, Farkhad; Schneider, Christian; Behr, Juergen und Tufman, Amanda
(29. Januar 2022):
Consequences of the COVID-19 pandemic on lung cancer care and patient health in a German lung cancer center: results from a cross-sectional questionnaire.
In: Respiratory Research, Bd. 23
[PDF, 1MB]
Taugner, Julian; Käsmann, Lukas; Karin, Monika; Eze, Chukwuka; Flörsch, Benedikt; Guggenberger, Julian; Li, Minglun; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus und Manapov, Farkhad
(2022):
Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition.
In: Investigational new drugs, Bd. 40: S. 163-171
[PDF, 1MB]
Kauffmann-Guerrero, Diego ORCID: https://orcid.org/0000-0003-1471-3290; Walter, Julia; Kovács, Julia; Sellmer, Laura; Hatz, Rudolf A.; Behr, Jürgen ORCID: https://orcid.org/0000-0002-9151-4829; Schubert-Fritschle, Gabriele; Tufman, Amanda und Schneider, Christian P.
(2022):
The Role of Thoracic Surgery in Small Cell Lung Cancer – A Large Longitudinal Analysis (2002-2015) Based on Real-World Data.
In: Clinical Lung Cancer, Bd. 23, Nr. 3: S. 244-252
ORCID: https://orcid.org/0000-0003-1471-3290; Walter, Julia; Kovács, Julia; Sellmer, Laura; Hatz, Rudolf A.; Behr, Jürgen ORCID: https://orcid.org/0000-0002-9151-4829; Schubert-Fritschle, Gabriele; Tufman, Amanda und Schneider, Christian P.
(2022):
The Role of Thoracic Surgery in Small Cell Lung Cancer – A Large Longitudinal Analysis (2002-2015) Based on Real-World Data.
In: Clinical Lung Cancer, Bd. 23, Nr. 3: S. 244-252
Unterrainer, Lena M.; Todica, Andrei; Beyer, Leonie; Brendel, Matthias; Holzgreve, Adrien; Kauffmann-Guerrero, Diego; Unterrainer, Marcus; Bartenstein, Peter und Tufman, Amanda
(2022):
Ga-68-EMP-100 PET/CT-a novel method for non-invasive assessment of c-MET expression in non-small cell lung cancer.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 50, Nr. 2: S. 628-629
[PDF, 412kB]
Heinrich, Kathrin; Miller-Phillips, Lisa; Ziemann, Frank; Hasselmann, Korbinian; Rühlmann, Katharina; Flach, Madeleine; Biro, Dorottya; Bergwelt-Baildon, Michael von; Holch, Julian; Herold, Tobias; Baumgarten, Louisa von; Greif, Philip A. ORCID: https://orcid.org/0000-0002-3744-7936; Jeremias, Irmela; Wuerstlein, Rachel; Casuscelli, Jozefina; Spitzweg, Christine; Seidensticker, Max; Renz, Bernhard; Corradini, Stefanie; Baumeister, Philipp; Goni, Elisabetta; Tufman, Amanda; Jung, Andreas; Kumbrink, Jörg; Kirchner, Thomas; Klauschen, Frederick; Metzeler, Klaus H.; Heinemann, Volker und Westphalen, C. Benedikt ORCID: https://orcid.org/0000-0002-5310-3754
(2022):
Lessons learned: the first consecutive 1000 patients of the CCCMunich(LMU) Molecular Tumor Board.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 5: S. 1905-1915
[PDF, 728kB]
ORCID: https://orcid.org/0000-0002-3744-7936; Jeremias, Irmela; Wuerstlein, Rachel; Casuscelli, Jozefina; Spitzweg, Christine; Seidensticker, Max; Renz, Bernhard; Corradini, Stefanie; Baumeister, Philipp; Goni, Elisabetta; Tufman, Amanda; Jung, Andreas; Kumbrink, Jörg; Kirchner, Thomas; Klauschen, Frederick; Metzeler, Klaus H.; Heinemann, Volker und Westphalen, C. Benedikt ORCID: https://orcid.org/0000-0002-5310-3754
(2022):
Lessons learned: the first consecutive 1000 patients of the CCCMunich(LMU) Molecular Tumor Board.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 5: S. 1905-1915
[PDF, 728kB]
Flörsch, Benedikt; Taugner, Julian; Käsmann, Lukas; Kenndoff, Saskia; Guggenberger, Julian; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus; Eze, Chukwuka und Manapov, Farkhad
(2022):
Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy +/- immune checkpoint inhibition: a decade-long single-center historical analysis.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 7: S. 3267-3276
[PDF, 1MB]
Bolt, Toki; Tufman, Amanda; Sellmer, Laura; Kahnert, Kathrin; Mertsch, Pontus; Kovacs, Julia; Kauffmann-Guerrero, Diego; Munker, Dieter; Manapov, Farkhad; Schneider, Christian; Behr, Jürgen und Walter, Julia
(2022):
Changes in Behavior After Vaccination and Opinions Toward Mask Wearing: Thoracic Oncology Patient-Reported Experiences During the COVID-19 Pandemic.
In: Clinical Medicine Insights-Oncology, Bd. 16
[PDF, 1MB]
Bozorgmehr, Farastuk; Eichhorn, Florian; Tufman, Amanda; Rieken, Stefan und Thomas, Michael
(2022):
Thorakale Onkologie – frühe Stadien.
In: Onkologe, Bd. 28, Nr. SUPPL 1: S. 50-54
Käsmann, Lukas; Taugner, Julian; Eze, Chukwuka; Nieto, Alexander; Pelikan, Carolyn; Flörsch, Benedikt; Kenndoff, Saskia; Hofer, Thomas P.; Nössner, Elfriede; Schulz, Christian; Unterrainer, Marcus; Tufman, Amanda; Klauschen, Frederick; Jung, Andreas; Neumann, Jens; Kumbrink, Jorg; Reinmuth, Niels; Bartenstein, Peter; Belka, Claus und Manapov, Farkhad
(2022):
Prospective evaluation of immunological, molecular-genetic, image-based and microbial analyses to characterize tumor response and control in patients with unresectable stage III NSCLC treated with concurrent chemoradiotherapy followed by consolidation therapy with durvalumab (PRECISION): protocol for a prospective longitudinal biomarker study.
In: Translational Lung Cancer Research, Bd. 11, Nr. 7: S. 1503-1509
[PDF, 294kB]
Shan, Longyu; Zhang, Liang; Zhu, Xiaolei; Wang, Zhilin; Fang, Shaohan; Lin, Junfeng; Wang, Jianweng; Li, Ning; Liu, Hongming; Zhang, Xiaowen; Feng, Yihui; Liu, Jingwei; Pan, Jianyun; Ye, Guanzhi; Yu, Xiuyi; Tufman, Amanda; Katalinic, Alexander; Goldmann, Torsten; Petersen, Frank; Jiang, Jie; Geng, Guojun und Yu, Xinhua
(2022):
Chinese never smokers with adenocarcinoma of the lung are younger and have fewer lymph node metastases than smokers.
In: Respiratory Research, Bd. 23, Nr. 1, 293
Kauffmann-Guerrero, Diego und Tufman, Amanda
(2022):
Rare driver alterations in nonsmall cell lung cancer: novel targeted drugs.
In: Current Opinion in Oncology, Bd. 34, Nr. 1: S. 77-82
Trudzinski, Franziska C.; Joerres, Rudolf A.; Alter, Peter; Walter, Julia; Watz, Henrik; Koch, Andrea; John, Matthias; Lommatzsch, Marek; Vogelmeier, Claus F.; Kauczor, Hans-Ulrich; Welte, Tobias; Behr, Juergen; Tufman, Amanda; Bals, Robert; Herth, Felix J. F. und Kahnert, Kathrin
(2022):
Sex-specific associations of comorbidome and pulmorbidome with mortality in chronic obstructive pulmonary disease: results from COSYCONET.
In: Scientific Reports, Bd. 12, Nr. 1, 8790
Zimmermann, Julia; Glueck, Olaf M.; Fertmann, Jan M.; Sienel, Wulf G.; Yavuz, Goekce; Damirov, Fuad; Kovacs, Julia R.; Tufman, Amanda; Irlbeck, Michael; Kneidinger, Nikolaus; Michel, Sebastian; Kauke, Teresa; Hatz, Rudolf A. und Schneider, Christian P.
(2022):
COVID-19 in Recent Lung Transplant Recipients: Clinical Outcomes and Management Strategies.
In: Transplantation Proceedings, Bd. 54, Nr. 6: S. 1504-1516
Tufman, Amanda; Redmond, Kathy; Giannopoulou, Andromachi; Gonzalez-McQuire, Sebastian; Varriale, Pasquale; Geltenbort-Rost, Lena; Oehrling, Katarina und Scheffler, Matthias
(2022):
Patient perception of burden of disease and treatment preferences in non-small cell lung cancer: Results from a European survey.
In: Lung Cancer, Bd. 168: S. 59-66
Christopoulos, Petros; Kluck, Klaus; Kirchner, Martina; Lueders, Heike; Roeper, Julia; Falkenstern-Ge, Roger-Fei; Szewczyk, Marlen; Sticht, Florian; Saalfeld, Felix C.; Wesseler, Claas; Hackanson, Bjoern; Dintner, Sebastian; Faehling, Martin; Kuon, Jonas; Janning, Melanie; Kauffmann-Guerrero, Diego; Kazdal, Daniel; Kurz, Sylke; Eichhorn, Florian; Bozorgmehr, Farastuk; Shah, Rajiv; Tufman, Amanda; Wermke, Martin; Loges, Sonja; Brueckl, Wolfgang M.; Schulz, Christian; Misch, Daniel; Frost, Nikolaj; Kollmeier, Jens; Reck, Martin; Griesinger, Frank; Grohe, Christian; Hong, Jin-Liern; Lin, Huamao M.; Budczies, Jan; Stenzinger, Albrecht und Thomas, Michael
(2022):
The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions.
In: European Journal of Cancer, Bd. 170: S. 106-118
Unterrainer, Marcus; Taugner, Julian; Käsmann, Lukas; Tufman, Amanda; Reinmuth, Niels; Li, Minglun; Mittlmeier, Lena M.; Bartenstein, Peter; Kunz, Wolfgang G.; Ricke, Jens; Belka, Claus; Eze, Chukwuka und Manapov, Farkhad
(2021):
Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition.
In: European journal of nuclear medicine and molecular imaging
[PDF, 848kB]
Endres, Felix; Spiro, Judith Eva; Bolt, Toki Anna; Tufman, Amanda; Ockert, Ben; Helfen, Tobias; Gilbert, Fabian; Holzapfel, Boris M.; Böcker, Wolfgang und Siebenbürger, Georg ORCID: https://orcid.org/0000-0002-0529-9326
(2021):
One-year follow-up-case report of secondary tension pneumothorax in a COVID-19 pneumonia patient.
In: Infection, Bd. 50: S. 525-529
[PDF, 690kB]
ORCID: https://orcid.org/0000-0002-0529-9326
(2021):
One-year follow-up-case report of secondary tension pneumothorax in a COVID-19 pneumonia patient.
In: Infection, Bd. 50: S. 525-529
[PDF, 690kB]
Brueckl, Wolfgang M.; Reck, Martin; Rittmeyer, Achim; Kollmeier, Jens; Wesseler, Claas; Wiest, Gunther H.; Christopoulos, Petros; Stenzinger, Albrecht; Tufman, Amanda; Hoffknecht, Petra; Ulm, Bernhard; Reich, Fabian; Ficker, Joachim H. und Laack, Eckart
(2021):
Efficacy of docetaxel plus ramucirumab as palliative second-line therapy following first-line chemotherapy plus immune-checkpoint-inhibitor combination treatment in patients with non-small cell lung cancer (NSCLC) UICC stage IV.
In: Translational Lung Cancer Research, Bd. 10, Nr. 7: S. 3093-3106
Budczies, Jan; Kirchner, Martina; Kluck, Klaus; Kazdal, Daniel; Glade, Julia; Allgaeuer, Michael; Kriegsmann, Mark; Heussel, Claus-Peter; Herth, Felix J.; Winter, Hauke; Meister, Michael; Muley, Thomas; Goldmann, Torsten; Froehling, Stefan; Wermke, Martin; Waller, Cornelius F.; Tufman, Amanda; Reck, Martin; Peters, Solange; Schirmacher, Peter; Thomas, Michael; Christopoulos, Petros und Stenzinger, Albrecht
(2021):
Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma.
In: Cancer Immunology Immunotherapy, Bd. 71, Nr. 2: S. 251-265
Endres, Felix; Spiro, Judith Eva; Bolt, Toki Anna; Tufman, Amanda; Ockert, Ben; Helfen, Tobias; Gilbert, Fabian; Holzapfel, Boris M.; Böcker, Wolfgang und Siebenbuerger, Georg
(2021):
One-year follow-up-case report of secondary tension pneumothorax in a COVID-19 pneumonia patient.
In: Infection, Bd. 50, Nr. 2: S. 525-529
Eze, Chukwuka; Schmidt-Hegemann, Nina-Sophie; Sawicki, Lino Morris; Kirchner, Julian; Roengvoraphoj, Olarn; Kaesmann, Lukas; Mittlmeier, Lena M.; Kunz, Wolfgang G.; Tufman, Amanda; Dinkel, Julien; Ricke, Jens; Belka, Claus; Manapov, Farkhad und Unterrainer, Marcus
(2021):
PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC-current state and future directions.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 48, Nr. 12: S. 3975-3989
Illini, Oliver; Hochmair, Maximilian Johannes; Fabikan, Hannah; Weinlinger, Christoph; Tufman, Amanda; Swalduz, Aurelie; Lamberg, Kristina; Hashemi, Sayed M. S.; Huemer, Florian; Vikstrom, Anders; Wermke, Martin; Absenger, Gudrun; Addeo, Alfredo; Banerji, Shantanu; Calles, Antonio; Clarke, Stephen; Di Maio, Massimo; Durand, Alice; Duruisseaux, Michael; Itchins, Malinda; Kaaranien, Okko-Sakari; Krenn, Florian; Laack, Eckart; de Langen, Adrianus Johannes; Mohorcic, Katja; Pall, Georg; Passaro, Antonio; Prager, Gerald; Rittmeyer, Achim; Rothenstein, Jeffrey; Schumacher, Michael; Woell, Ewald und Valipour, Arschang
(2021):
Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program.
In: Therapeutic Advances in Medical Oncology, Bd. 13, 17588359211019675
Kauffmann-Guerrero, Diego; Kahnert, Kathrin; Kiefl, Rosemarie; Sellmer, Laura; Walter, Julia; Behr, Jürgen und Tufman, Amanda
(2021):
Systemic inflammation and pro-inflammatory cytokine profile predict response to checkpoint inhibitor treatment in NSCLC: a prospective study.
In: Scientific Reports, Bd. 11, Nr. 1, 10919
Kauffmann-Guerrero, Diego; Kahnert, Kathrin; Kiefl, Rosemarie; Sellmer, Laura; Walter, Julia; Behr, Jürgen und Tufman, Amanda
(2021):
Systemic inflammation and pro-inflammatory cytokine profile predict response to checkpoint inhibitor treatment in NSCLC: a prospective study.
In: Scientific reports, Bd. 11, Nr. 1, 10919
[PDF, 2MB]
Kauffmann-Guerrero, Diego; Taugner, Julian; Eze, Chukwuka; Kaesmann, Lukas; Li, Minglun; Tufman, Amanda und Manapov, Farkhad
(2021):
Clinical Management and Outcome of Grade III Pneumonitis after Chemoradioimmunotherapy for Inoperable Stage III Non-Small Cell Lung Cancer-A Prospective Longitudinal Assessment.
In: Diagnostics, Bd. 11, Nr. 11, 1968
Kocher, Florian; Tymoszuk, Piotr; Amann, Arno; Sprung, Susanne; Salcher, Stefan; Daum, Sophia; Haybaeck, Johannes; Rinnerthaler, Gabriel; Huemer, Florian; Kauffmann-Guerrero, Diego; Tufman, Amanda; Seeber, Andreas; Wolf, Dominik und Pircher, Andreas
(2021):
Deregulated glutamate to pro-collagen conversion is associated with adverse outcome in lung cancer and may be targeted by renin-angiotensin-aldosterone system (RAS) inhibition.
In: Lung Cancer, Bd. 159: S. 84-95
Liu, Dong; Liu, Xiao-qing; Kiefl, Rosemarie; Zhang, Wei; Xu, Yin-hui und Tufman, Amanda
(2021):
Effects of the NF-kappa B Pathway Agonist IL-1 beta on Non-Small Cell Lung Cancer Cell Lines.
In: Annals of Clinical and Laboratory Science, Bd. 51, Nr. 3: S. 295-301
Pazos, Montserrat; Eze, Chukwuka; Kahnert, Kathrin; Delius, Maria; Tufman, Amanda; Alba-Alejandre, Irene; Unterrainer, Marcus; Neumann, Jens; Kirchner, Thomas und Manapov, Farkhad
(2021):
Novel Multimodal Management of Post-Partum Synchronous Metastatic Pulmonary EBV-Associated Lymphoepithelioma-Like Carcinoma (LELC)-A Case Report.
In: Diagnostics, Bd. 11, Nr. 11, 2072
Bickert, Christiane ORCID: https://orcid.org/0000-0003-4121-6687; Kahnert, Kathrin; Kauffmann-Guerrero, Diego; Götschke, Jeremias ORCID: https://orcid.org/0000-0002-3426-2194; Syunyaeva, Zulfiya; Behr, Jürgen und Tufman, Amanda
(2021):
Osimertinib rechallenge under steroid protection following osimertinib-induced pneumonitis: three case studies.
In: Therapeutic Advances in Medical Oncology, Bd. 13, 17588359211018028: S. 1-7
[PDF, 2MB]
ORCID: https://orcid.org/0000-0003-4121-6687; Kahnert, Kathrin; Kauffmann-Guerrero, Diego; Götschke, Jeremias ORCID: https://orcid.org/0000-0002-3426-2194; Syunyaeva, Zulfiya; Behr, Jürgen und Tufman, Amanda
(2021):
Osimertinib rechallenge under steroid protection following osimertinib-induced pneumonitis: three case studies.
In: Therapeutic Advances in Medical Oncology, Bd. 13, 17588359211018028: S. 1-7
[PDF, 2MB]
Eze, Chukwuka; Schmidt-Hegemann, Nina-Sophie; Sawicki, Lino Morris; Kirchner, Julian; Roengvoraphoj, Olarn; Käsmann, Lukas; Mittlmeier, Lena M.; Kunz, Wolfgang G.; Tufman, Amanda; Dinkel, Julien; Ricke, Jens; Belka, Claus ORCID: https://orcid.org/0000-0002-1287-7825; Manapov, Farkhad und Unterrainer, Marcus
(2021):
PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC-current state and future directions.
In: European journal of nuclear medicine and molecular imaging
[PDF, 3MB]
ORCID: https://orcid.org/0000-0002-1287-7825; Manapov, Farkhad und Unterrainer, Marcus
(2021):
PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC-current state and future directions.
In: European journal of nuclear medicine and molecular imaging
[PDF, 3MB]
Taugner, Julian; Käsmann, Lukas; Eze, Chukwuka; Rühle, Alexander; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus ORCID: https://orcid.org/0000-0002-1287-7825 und Manapov, Farkhad
(2021):
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients.
In: Investigational new drugs, Bd. 39: S. 1189-1196
[PDF, 586kB]
ORCID: https://orcid.org/0000-0002-1287-7825 und Manapov, Farkhad
(2021):
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients.
In: Investigational new drugs, Bd. 39: S. 1189-1196
[PDF, 586kB]
Saalfeld, Felix C.; Wenzel, Carina; Christopoulos, Petros; Merkelbach-Bruse, Sabine; Reissig, Timm M.; Lassmann, Silke; Thiel, Sebastian; Stratmann, Jan A.; Marienfeld, Ralf; Berger, Johannes; Desuki, Alexander; Velthaus, Janna-Lisa; Kauffmann-Guerrero, Diego; Stenzinger, Albrecht; Michels, Sebastian; Herold, Thomas; Kramer, Michael; Herold, Sylvia; Tufman, Amanda; Loges, Sonja; Alt, Jürgen; Joosten, Maria; Schmidtke-Schrezenmeier, Gerlinde; Sebastian, Martin; Stephan-Falkenau, Susann; Waller, Cornelius F.; Wiesweg, Marcel; Wolf, Jürgen; Thomas, Michael; Aust, Daniela E. und Wermke, Martin
(2021):
Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations.
In: Journal of Thoracic Oncology, Bd. 16, Nr. 11: S. 1952-1958
Sellmer, Laura; Kovacs, Julia; Neumann, Jens; Walter, Julia; Kauffmann-Guerrero, Diego; Syunyaeva, Zulfiya; Fertmann, Jan; Schneider, Christian; Zimmermann, Julia; Behr, Jürgen und Tufman, Amanda
(2021):
Lymphocytes and sinus histiocytosis in tumor and matched lymph nodes as predictors of survival in non-small-cell lung cancer.
In: Future Oncology, Bd. 18, Nr. 4: S. 481-490
Taugner, Julian; Kaesmann, Lukas; Eze, Chukwuka; Ruehle, Alexander; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus und Manapov, Farkhad
(2021):
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients.
In: Investigational New Drugs, Bd. 39, Nr. 4: S. 1189-1196
Taugner, Julian; Käsmann, Lukas; Eze, Chukwuka; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus und Manapov, Farkhad
(2021):
Durvalumab after Chemoradiotherapy for PD-L1 Expressing Inoperable Stage III NSCLC Leads to Significant Improvement of Local-Regional Control and Overall Survival in the Real-World Setting.
In: Cancers, Bd. 13, Nr. 7, 1613
Taugner, Julian; Käsmann, Lukas; Karin, Monika; Eze, Chukwuka; Flörsch, Benedikt; Guggenberger, Julian; Li, Minglun; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus und Manapov, Farkhad
(2021):
Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition.
In: Investigational New Drugs, Bd. 40, Nr. 1: S. 163-171
Tufman, Amanda; Neumann, Jens; Manapov, Farkhad; Sellmer, Laura; Jung, Andreas; Kauffmann-Guerrero, Diego; Kahnert, Kathrin; Mertsch, Pontus; Borgmeier, Astrid; Semrau, Sabine; Rittmeyer, Achim; Ulm, Bernhard; Ulm, Kurt; Flentje, Michael; Fietkau, Rainer und Huber, Rudolf Maria
(2021):
Prognostic and predictive value of PD-L1 expression and tumour infiltrating lymphocytes (TiLs) in locally advanced NSCLC treated with simultaneous radiochemotherapy in the randomized, multicenter, phase III German Intergroup lung Trial (GILT).
In: Lung Cancer, Bd. 160: S. 17-27
Unterrainer, Marcus; Taugner, Julian; Kasmann, Lukas; Tufman, Amanda; Reinmuth, Niels; Li, Minglun; Mittlmeier, Lena M.; Bartenstein, Peter; Kunz, Wolfgang G.; Ricke, Jens; Belka, Claus; Eze, Chukwuka und Manapov, Farkhad
(2021):
Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy +/- immune checkpoint inhibition.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 49, Nr. 4: S. 1407-1416
Liu, Yichao; Huber, Rudolf M.; Kiefl, Rosemarie; Tufman, Amanda und Kauffmann-Guerrero, Diego
(2020):
Hedgehog Pathway Activation Might Mediate Pemetrexed Resistance in NSCLC Cells.
In: Anticancer Research, Bd. 40, Nr. 3: S. 1451-1458
Karin, Monika; Taugner, Julian; Kaesmann, Lukas; Eze, Chukwuka; Roengvoraphoj, Olarn; Tufman, Amanda; Belka, Claus und Manapov, Farkhad
(2020):
Association of Planning Target Volume with Patient Outcome in Inoperable Stage III NSCLC Treated with Chemoradiotherapy: A Comprehensive Single-Center Analysis.
In: Cancers, Bd. 12, Nr. 10, 3035
Liu, Xiaoqing; Tufman, Amanda; Behr, Jürgen; Kiefl, Rosemarie; Goldmann, Torsten und Huber, Rudolf M.
(2020):
Role of the erythropoietin receptor in Lung Cancer cells: erythropoietin exhibits angiogenic potential.
In: Journal of Cancer, Bd. 11, Nr. 20: S. 6090-6100
Kauffmann-Guerrero, Diego; Tufman, Amanda; Kahnert, Kathrin; Bollmann, Benjamin Alexander; Reu, Simone; Syunyaeva, Zulfiya; Schneider, Christian; Manapov, Farkhad; Huber, Rudolf M. und Golpon, Heiko
(2020):
Response to Checkpoint Inhibition in Non-Small Cell Lung Cancer with Molecular Driver Alterations.
In: Oncology Research and Treatment, Bd. 43, Nr. 6: S. 289-297
Salazar, Ylia; Zheng, Xiang; Brunn, David; Raifer, Hartmann; Picard, Felix; Zhang, Yajuan; Winter, Hauke; Guenther, Stefan; Weigert, Andreas; Weigmann, Benno; Dumoutier, Laure; Renauld, Jean-Christophe; Waisman, Ari; Schmall, Anja; Tufman, Amanda; Fink, Ludger; Bruene, Bernhard; Bopp, Tobias; Grimminger, Friedrich; Seeger, Werner; Pullamsetti, Soni Savai; Huber, Magdalena und Savai, Rajkumar
(2020):
Microenvironmental Th9 and Th17 lymphocytes induce metastatic spreading in lung cancer.
In: Journal of Clinical Investigation, Bd. 130, Nr. 7: S. 3560-3575
Brückl, Wolfgang M.; Reck, Martin; Rittmeyer, Achim; Kollmeier, Jens; Wesseler, Claas; Wiest, Gunther H.; Christopoulos, Petros; Tufman, Amanda; Hoffknecht, Petra; Ulm, Bernhard; Reich, Fabian; Ficker, Joachim H. und Laack, Eckart
(2020):
Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV.
In: Clinical Medicine Insights-Oncology, Bd. 14: S. 1-9
[PDF, 433kB]
Gennen, Kathrin; Kaesmann, Lukas; Taugner, Julian; Eze, Chukwuka; Karin, Monika; Roengvoraphoj, Olarn; Neumann, Jens; Tufman, Amanda; Orth, Michael; Reu, Simone; Belka, Claus und Manapov, Farkhad
(2020):
Prognostic value of PD-L1 expression on tumor cells combined with CD8+TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.
In: Radiation Oncology, Bd. 15, Nr. 1, 5
Taugner, Julian; Eze, Chukwuka; Kaesmann, Lukas; Roengvoraphoj, Olarn; Gennen, Kathrin; Karin, Monika; Petrukhnov, Oleg; Tufman, Amanda; Belka, Claus und Manapov, Farkhad
(2020):
Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer.
In: Radiation Oncology, Bd. 15, Nr. 1, 148
Roengvoraphoj, Olarn; Kaesmann, Lukas; Eze, Chukwuka; Taugner, Julian; Gjika, Arteda; Tufman, Amanda; Hadi, Indrawati; Li, Minglun; Mille, Erik; Gennen, Kathrin; Belka, Claus und Manapov, Farkhad
(2020):
Maximum standardized uptake value of primary tumor (SUVmax_PT) and horizontal range between two most distant PET-positive lymph nodes predict patient outcome in inoperable stage III NSCLC patients after chemoradiotherapy.
In: Translational Lung Cancer Research, Bd. 9, Nr. 3: S. 541-548
Kauffmann-Guerrero, Diego; Kahnert, Kathrin; Kumbrink, Jörg; Syunyaeva, Zulfiya; Tufman, Amanda und Huber, Rudolf M.
(2019):
Successful Treatment of a Patient With NSCLC Harboring an EGFR Mutation and a Concomitant Met Exon 14 Skipping Mutation Combining Afatinib and Crizotinib.
In: Clinical Lung Cancer, Bd. 20, Nr. 1: S. 59-62
Tufman, Amanda; Duell, Thomas und Schneider, Christian
(2019):
Die Nachsorge des Lungenkarzinoms.
In: Zentralblatt für Chirurgie, Bd. 144, Nr. 1: S. 106-117
Kauffmann-Guerrero, Diego; Schindler, Andreas; Tufman, Amanda; Syunyaeva, Zulfiya; Pfluger, Thomas; Huber, Rudolf Maria; Berger, Frank und Kahnert, Kathrin
(2019):
Response assessment in non-small cell lung cancer immunotherapy: initial experiences in utilizing FDG PET/CT and the PD-1 blocker nivolumab.
In: Memo-Magazine of European Medical Oncology, Bd. 12, Nr. 2: S. 149-155
Huber, Rudolf M.; De Ruysscher, Dirk; Hoffmann, Hans; Reu, Simone und Tufman, Amanda
(2019):
Interdisciplinary multimodality management of stage III nonsmall cell lung cancer.
In: European Respiratory Review, Bd. 28, Nr. 152, 190024
Kaesmann, Lukas; Taugner, Julian; Eze, Chukwuka; Roengvoraphoj, Olarn; Dantes, Maurice; Gennen, Kathrin; Karin, Monika; Petrukhnov, Oleg; Tufman, Amanda; Belka, Claus und Manapov, Farkhad
(2019):
Performance Status and Its Changes Predict Outcome for Patients With Inoperable Stage III NSCLC Undergoing Multimodal Treatment.
In: Anticancer Research, Bd. 39, Nr. 9: S. 5077-5081
Taugner, Julian; Kaesmann, Lukas; Eze, Chukwuka; Dantes, Maurice; Roengvoraphoj, Olarn; Gennen, Kathrin; Karin, Monika; Petruknov, Oleg; Tufman, Amanda; Belka, Claus und Manapov, Farkhad
(2019):
Survival score to characterize prognosis in inoperable stage III NSCLC after chemoradiotherapy.
In: Translational Lung Cancer Research, Bd. 8, Nr. 5: S. 593-604
Roengvoraphoj, Olarn; Wijaya, Cherylina; Eze, Chukwuka; Li, Minglun; Dantes, Maurice; Taugner, Julian; Tufman, Amanda; Huber, Rudolf Maria; Belka, Claus und Manapov, Farkhad
(2018):
Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer.
In: Strahlentherapie und Onkologie, Bd. 194, Nr. 2: S. 107-115
Roengvoraphoj, Olarn; Eze, Chukwuka; Wijaya, Cherylina; Dantes, Maurice; Taugner, Julian; Tufman, Amanda; Huber, Rudolf Maria; Bartenstein, Peter; Belka, Claus und Manapov, Farkhad
(2018):
How much primary tumor metabolic volume reduction is required to improve outcome in stage III NSCLC after chemoradiotherapy? A single-centre experience.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 45, Nr. 12: S. 2103-2109
Kauffmann-Guerrero, Diego; Huber, Rudolf Maria; Reu, Simone; Tufman, Amanda; Mertsch, Pontus; Syunyaeva, Zulfiya; Jung, Andreas und Kahnert, Kathrin
(2018):
NSCLC Patients Harbouring Rare or Complex EGFR Mutations Are More Often Smokers and Might Not Benefit from First-Line Tyrosine Kinase Inhibitor Therapy.
In: Respiration, Bd. 95, Nr. 3: S. 169-176
Kauffmann-Guerrero, Diego; Kahnert, Kathrin; Syunyaeva, Zulfiya; Tufman, Amanda und Huber, Rudolf M.
(2018):
Pretherapeutic Inflammation Predicts Febrile Neutropenia and Reduced Progression-Free Survival after First-Line Chemotherapy in SCLC.
In: Oncology Research and Treatment, Bd. 41, Nr. 9: S. 506-512
Heinrich, Daniel A.; Reinholz, Claudia; Bauer, Maximilian; Tufman, Amanda; Frohner, Richard; Schopohl, Jochen; Bidlingmaier, Martin; Kosilek, Robert P.; Reincke, Martin und Schneider, Harald J.
(2018):
Interdisziplinäre Task-Force der DGPPN.
In: Endocrine, Bd. 60, Nr. 2: S. 317-322
Walter, Julia; Tufman, Amanda; Leidl, Reiner; Holle, Rolf und Schwarzkopf, Larissa
(2018):
Rural versus urban differences in end-of-life care for lung cancer patients in Germany.
In: Supportive Care in Cancer, Bd. 26, Nr. 7: S. 2275-2283
Müller-Lisse, Ullrich G.; Marwitz, Larissa; Tufman, Amanda; Huber, Rudolf M.; Zimmermann, Hanna A.; Walterham, Annemarie; Wirth, Stefan und Paolini, Marco
(2018):
Less radiation, same quality: contrast-enhanced multi-detector computed tomography investigation of thoracic lymph nodes with one milli-sievert.
In: Radiologia Medica, Bd. 123, Nr. 11: S. 818-826
Gütz, Sylvia; Tufman, Amanda; Pawel, Joachim von; Rittmeyer, Achim; Borgmeier, Astrid; Ferre, Pierre; Edlich, Birgit und Huber, Rudolf Maria
(2017):
Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine - a Phase I trial.
In: Oncotargets and therapy, Bd. 10: S. 1081-1089
[PDF, 679kB]
Tufman, Amanda; Kahnert, Kathrin; Duell, Thomas; Kauffmann-Guerrero, Diego; Milger, Katrin; Schneider, Christian; Stump, Julia; Syunyaeva, Zulfiya; Huber, Rudolf Maria und Reu, Simone
(2017):
Frequency and clinical relevance of EGFR mutations and EML4-ALK translocations in octogenarians with non-small cell lung cancer.
In: Oncotargets and therapy, Bd. 10: S. 5179-5186
[PDF, 535kB]
Müller-Lisse, Ullrich G.; Zimmermann, Hanna A.; Reiners, Carolina; Reu, Simone; Reiser, Maximilian F.; Huber, Rudolf M. und Tufman, Amanda
(2017):
Distinct computed tomography features of non-small-cell lung cancer in a European population with EML4-ALK translocation.
In: Memo-Magazine of European Medical Oncology, Bd. 10, Nr. 2: S. 94-102
Tufman, Amanda; Kahnert, Kathrin; Kauffmann-Guerrero, Diego; Manapov, Farkhad; Milger, Katrin; Müller-Lisse, Ullrich; Winter, Hauke; Huber, Rudolf Maria und Schneider, Christian
(2017):
Clinical relevance of the M1b and M1c descriptors from the proposed TNM 8 classification of lung cancer.
In: Strahlentherapie und Onkologie, Bd. 193, Nr. 5: S. 392-401
Kauffmann-Guerrero, Diego; Kahnert, Kathrin; Pratschke, Sebastian; Angstwurm, Matthias; Tufman, Amanda und Huber, Rudolf Maria
(2017):
Black and Blue.
In: Respiration, Bd. 94, Nr. 5: S. 465-466
Kahnert, Kathrin; Kauffmann-Guerrero, Diego; Tufman, Amanda; Borgmeier, Astrid; Huber, Rudolf M. und Berger, Frank
(2017):
Cancer vaccination causes prolonged FDG accumulation in subcutaneous tissue.
In: Nuklearmedizin-Nuclear Medicine, Bd. 56, Nr. 3:
N22-N23
Tufman, Amanda; Reu, Simone; Hasmann, Sandra; Kauffmann-Guerrero, Diego; Milger, Katrin; Syunyaeva, Zulfiya; Kahnert, Kathrin und Huber, Rudolf
(2017):
Frequency and Clinical Relevance of EGFR-Mutations and EML4-ALK-Translocations in Octagenarians with NSCLC.
In: Journal of thoracic Oncology, Bd. 12, Nr. 1:
S686-S687
Tufman, Amanda; Siokou, Fiona; Müller-Lisse, Ullrich; Berger, Frank; Kahnert, Kathrin; Pfluger, Thomas; Reu, Simone; Stump, Julia; Winter, Hauke und Huber, Rudolf
(2017):
Clinical and Histological Features Associated with SUV in FDG-PET-CT in Patients with Adenocarcinoma of the Lung.
In: Journal of thoracic Oncology, Bd. 12, Nr. 1:
S558-S558
Brückl, Wolfgang; Tufman, Amanda und Huber, Rudolf Maria
(2017):
Advanced non-small cell lung cancer (NSCLC) with activating EGFR mutations: first-line treatment with afatinib and other EGFR TKIs.
In: Expert Review of Anticancer therapy, Bd. 17, Nr. 2: S. 143-155
Paolini, Marco; Wirth, Kathrin; Tufman, Amanda; Reiser, Maximilian; Huber, Rudolf M. und Mueller-Lisse, Ullrich G.
(2016):
Thoracic lymph node delineation at dose-reduced (1 mSv) dose-modulated contrast enhanced MDCT: a retrospective pilot study.
In: Radiologia Medica, Bd. 121, Nr. 8: S. 644-651
Tian, Fei; Kiefl, Rosemarie; Tufman, Amanda und Huber, Rudolf
(2016):
The Hedgehog Pathway Inhibitor GDC-0449 Alters the Expression Level of the Pathway Components In Lung Cancer Cell Lines.
In: Chest, Bd. 149, Nr. 4:
299A-299A
Tufman, Amanda; Huber, Rudolf Maria; Volk, Stefanie; Aigner, Frederic; Edelmann, Martin; Gamarra, Fernando; Kiefl, Rosemarie; Kahnert, Kathrin; Tian, Fei; Boulesteix, Anne-Laure; Endres, Stefan und Kobold, Sebastian
(2016):
Interleukin-22 is elevated in lavage from patients with lung cancer and other pulmonary diseases.
In: BMC Cancer, Bd. 16: S. 409
Schrödl, Kathrin; Schilling, Christoph von; Tufman, Amanda; Huber, Rudolf Maria und Gamarra, Fernando
(2014):
Response to chemotherapy, reexposure to crizotinib and treatment with a novel ALK inhibitor in a patient with acquired crizotinib resistance.
In: Respiration, Bd. 88, Nr. 3: S. 262-264
[PDF, 65kB]
Kobold, Sebastian; Völk, Stefanie; Clauditz, Till; Küpper, Natascha Jennifer; Minner, Sarah; Tufman, Amanda; Düwell, Peter; Lindner, Michael; Koch, Ina; Heidegger, Simon; Rothenfußer, Simon; Schnurr, Max; Huber, Rudolf Maria; Wilczak, Waldemar und Endres, Stefan
(August 2013):
Interleukin-22 Is Frequently Expressed in Small- and Large-Cell Lung Cancer and Promotes Growth in Chemotherapy-Resistant Cancer Cells.
In: Journal of Thoracic Oncology, Bd. 8, Nr. 8: S. 1032-1042
[PDF, 1MB]
Ferrari, Uta; Exner, Teresa; Wanka, Eva R.; Bergemann, Christoph; Meyer-Arnek, Julian; Hildenbrand, Beate; Tufman, Amanda; Heumann, Christian; Huber, Rudof M.; Bittner, Michael und Fischer, Rainald
(2012):
Influence of air pressure, humidity, solar radiation, temperature and wind speed on ambulatory visits due to chronic obstructive pulmonary disease in Bavaria, Germany.
In: International Journal of Biometeorology, Bd. 56, Nr. 1: S. 137-143
Bergner, Albrecht; Kellner, Julia; Tufman, Amanda und Huber, Rudolf M.
(2009):
Endoplasmic reticulum Ca2+-homeostasis is altered in small and non-small cell lung cancer cell lines.
In: Journal of Experimental & Clinical Cancer Research
28:25
[PDF, 462kB]